Home
About us
Reports
Charts
News
Custom
Company Scan
Report
Charts
News
*
Title
Content
Economy&Goods
Economy
ConsumerGoods
Food&Beverage
Agriculture
Life Sciences
Biotechnology
Medical
Pharmaceutical
Manufacturing
Automotive
Chemical
Energy
Machinery
Material
Metals & Minerals
Public Sector
Environment
Finance Service
Infrastructure
Logistics
Real Estate
Retailing
Tourism
Training
Technology And Media
Electronics
Internet
Hardware
Media
Software
Telecommunications
Tel:
0086-10-82600828
Fax:
0086-10-82601570
Email:
Home
>
News
>
Life Sciences
>
Biotechnology
Beijing SL Pharmaceutical invested PnuVax and entered into high-end vaccine market
CreateTime:2011-09-08 Source:ResearchInChina
Editor:hangmei
Text Size:
Related Company：
Beijing SL Pharmaceutical Co.,Ltd.(002038.SZ)
Beijing SL Pharmaceutical announced on 13th Aug, that it will invest RMB130 million to set up joint-venture PnuVax SL with Canadian company PnuVax Incorporated. SL Pharmaceutical and PnuVax will ho...
UserName
*
PassWord
*
Validation Code
*
Remember Me Next Time
Forget password? get password
Welcome to our website.
This service is open to member only.
Contact our customer service team
Tel: 86-10-82600828, 82601561
Email: report@researchinchina.com
Related Reports
China Independent Clinical Laboratory Industry Report, 2019-2025
Global and China Industrial Enzyme Industry Report, 2014-2017
About RIC
|
Copyright
|
Contact Us
|
Privacy policy
|
Buy Reports
|
Member Service
|
Mailing List
2005-2021 www.researchinchina.com All Rights Reserved
京ICP备05069564号-1